Changes in meningococcal C epidemiology and vaccine effectiveness after vaccine introduction and schedule modification
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the NetherlandsBMC Infectious Diseases, 2012
- ANTIBODY PERSISTENCE 12 MONTHS AFTER A BOOSTER DOSE OF MENINGOCOCCAL-C CONJUGATED VACCINE IN THE SECOND YEAR OF LIFEThe Pediatric Infectious Disease Journal, 2010
- Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C VaccineClinical and Vaccine Immunology, 2010
- Meningococcal C conjugate vaccine: The experience in England and WalesVaccine, 2009
- Immunogenicity of a Reduced Schedule of Meningococcal Group C Conjugate Vaccine Given Concomitantly with the Prevenar and Pediacel Vaccines in Healthy Infants in the United KingdomClinical and Vaccine Immunology, 2009
- Seroprevalence of Antibodies against Serogroup C Meningococci in England in the Postvaccination EraClinical and Vaccine Immunology, 2008
- Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational studyBMJ, 2008
- Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: A model-based evaluationVaccine, 2006
- Increasing incidence of meningococcal disease in Spain associated with a new variant of serogroup CEuropean Journal of Clinical Microbiology & Infectious Diseases, 1998
- Estimation of Vaccine Effectiveness Using the Screening MethodInternational Journal of Epidemiology, 1993